"We offer a unique combination of extensive inhalation device development capability and long experience from pharmaceutical product development."
Iconovo has raised 2.3 million EUR to expand the in-house development capacity. We will now be able to offer a comprehensive product development including device, formulation and analytical testing.
Orest Lastow will be giving a talk at Dry Powder Inhalers conference 27-28 July in London. The title of the talk is "How to develop a generic DPI: from scratch to market".
Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the kind support from the EU financed SSGG project.
We welcome our two new associates; Richard Johnson and Fredrik Gunnarson. Richard is a mechanical engineer and Fredrik is an analytical chemist.